Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.

[1]  K. Harada,et al.  Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene. , 1997, Cancer letters.

[2]  S. Taviaux,et al.  Cloning of the Human Homologue of the TGFβ-Stimulated Clone 22 Gene , 1996 .

[3]  Xin-Yuan Fu,et al.  Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1 , 1996, Science.

[4]  K. Harada,et al.  Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice. , 1995, Cancer letters.

[5]  R. Pepperkok,et al.  Id proteins control growth induction in mammalian cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Todokoro,et al.  Activation of helix-loop-helix proteins Id1, Id2 and Id3 during neural differentiation. , 1994, Biochemical and biophysical research communications.

[7]  K. Hamil,et al.  Cloning of rat Sertoli cell follicle-stimulating hormone primary response complementary deoxyribonucleic acid: regulation of TSC-22 gene expression. , 1994, Endocrinology.

[8]  L. Philipson,et al.  CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. , 1994, Genes & development.

[9]  K. Harada,et al.  INDUCTION OF DIFFERENTIATION AND APOPTOSIS, AND Ley ANTIGEN EXPRESSION BY TREATMENT WITH 3, 4-DIHYDRO-6-[4-(3, 4-DIMETHOXYBENZOYL)-1-PIPERAZINYL]-2(1H)-QUINOLINONE (VESNARINONE) IN A HUMAN SALIVARY CANCER CELL LINE , 1994 .

[10]  J. Fargnoli,et al.  Isolation, characterization and chromosomal localization of the human GADD153 gene. , 1992, Gene.

[11]  K. Nose,et al.  Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. , 1992, The Journal of biological chemistry.

[12]  D. Ron,et al.  CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. , 1992, Genes & development.

[13]  J. Auwerx,et al.  IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation , 1991, Cell.

[14]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[15]  J. Fargnoli,et al.  Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents , 1989, Molecular and cellular biology.

[16]  S. Sasayama,et al.  Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure. , 1987, Journal of the American College of Cardiology.

[17]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[18]  T. Bando,et al.  An adenoid squamous carcinoma-forming cell line established from an oral keratinizing squamous cell carcinoma expressing carcinoembryonic antigen. , 1986, The American journal of pathology.